Compare IMCR & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMCR | HLF |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2016 | 2004 |
| Metric | IMCR | HLF |
|---|---|---|
| Price | $30.88 | $12.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $66.33 | $18.00 |
| AVG Volume (30 Days) | 556.7K | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.39 | N/A |
| EPS | 0.25 | ★ 0.57 |
| Revenue | $249,428,000.00 | ★ $5,037,500,000.00 |
| Revenue This Year | $14.57 | $4.97 |
| Revenue Next Year | $8.21 | $3.80 |
| P/E Ratio | $122.16 | ★ $21.00 |
| Revenue Growth | ★ 43.05 | 0.89 |
| 52 Week Low | $27.56 | $7.56 |
| 52 Week High | $40.71 | $20.40 |
| Indicator | IMCR | HLF |
|---|---|---|
| Relative Strength Index (RSI) | 61.86 | 50.91 |
| Support Level | $27.66 | $11.39 |
| Resistance Level | $31.56 | $13.09 |
| Average True Range (ATR) | 1.12 | 0.55 |
| MACD | 0.28 | 0.19 |
| Stochastic Oscillator | 73.84 | 77.51 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
Herbalife Ltd is a health and wellness company. It provides health and wellness products in 95 markets through a direct-selling business model. Its product categories include Weight Management, Targeted Nutrition, Energy, Sports and Fitness, Outer Nutrition, and Literature, Promotional, and Other. Weight Management generates the majority of revenue, with products such as meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Products are manufactured at facilities in Changsha and Suzhou, China; Lake Forest, California; and Winston-Salem, North Carolina, as well as by third-party providers. Revenues reflect sales to Members across North America, Latin America, EMEA, Asia Pacific, and China.